News | Proton Therapy | December 17, 2015

St. Jude Children's Research Hospital Opens New Proton Therapy Center

First proton center fully dedicated to pediatric cancer will feature Hitachi system with spot scanning irradiation technology

Hitachi, St. Jude Children's Research Hospital, Red Frog Events Proton Therapy Center

December 17, 2015 — Hitachi Ltd. announced that St. Jude Children’s Research Hospital opened the St. Jude Red Frog Events Proton Therapy Center in Memphis, Tennessee, the world’s first proton therapy center solely dedicated to children. The new center has 190-degree half gantries that provide efficient and spacious treatment-room environments suited specifically for pediatric care. All rooms are equipped with spot-scanning irradiation, a technology for which Hitachi received the first U.S. Food and Drug Administration (FDA) Premarket Notification Special 510(k) clearance in 2007.

St. Jude will be Hitachi’s third proton therapy site in the United States.

“The opening of the St. Jude Red Frog Events Proton Therapy Center marks an important step in our efforts to provide therapies that maximize cures while minimizing long-term treatment complications,” said James R. Downing, M.D., St. Jude president and chief executive officer. “The center is an engineering marvel made possible through the talents of many who are committed to offering children with cancer the best hope for the future.”

Radiation therapy, used alone or in combination with surgery and chemotherapy, is an integral component for successfully managing and treating pediatric tumors. Proton therapy allows doctors to administer targeted, high-dose radiation while sparing surrounding healthy tissue from exposure.

Proton beam therapy is an advanced form of external beam radiotherapy in which the protons from a hydrogen atom are extracted and accelerated up to 70 percent the speed of light. The energy beam is concentrated directly on the tumor, minimizing radiation doses to the surrounding healthy tissues. The procedure has fewer side effects compared to traditional radiotherapy.

Spot-scanning irradiation technology does not scatter proton beams like conventional proton beam therapy does. Rather, it repeatedly turns a narrow proton beam on and off at high speed as it progressively changes location to irradiate entire tumor volumes. Protons can be aimed with high precision at targeted tumors, even those with complex shapes, while minimizing the impact on nearby healthy tissue.

For more information: www.hitachi.com

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

News | Radiation Therapy | April 07, 2020
April 7, 2020 — An intern...
Eclipse v16 has received CE mark and is 510(k) pending
News | Proton Therapy | April 06, 2020
April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technolo
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center
News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020
February 27, 2020 — Accuray Incorporated announced that Mercy
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...